These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 30808376)

  • 1. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.
    Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y
    Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fbxo22 promotes cervical cancer progression via targeting p57
    Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X
    Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways.
    Chen T; Huang H; Zhou Y; Geng L; Shen T; Yin S; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):193. PubMed ID: 30111352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCF
    Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.
    Zhang Y; Liu Y; Duan J; Yan H; Zhang J; Zhang H; Fan Q; Luo F; Yan G; Qiao K; Liu J
    Hepatology; 2016 Mar; 63(3):880-97. PubMed ID: 26659654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
    Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
    Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
    PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
    Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC
    Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.